|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1-42 peptide alters the gating of human and mouse
-bungarotoxin-sensitive nicotinic receptors
The-amyloid1-42 peptide (A
1-42), a major constituent of the Alzheimer's disease amyloid plaque, specifically binds to the neuronal
-bungarotoxin (
-BuTx)-sensitive
7 nicotinic acetylcholine receptor (
7 nAChR). Accordingly, A
1-42 interferes with the function of
7 nAChRs in chick and rodent neurons. To gain insights into the human disease, we studied the action of A
1-42 on human
7 nAChRs expressed in Xenopus oocytes. In voltage-clamped oocytes expressing the wild-type receptor, A
1-42 blocked ACh-evoked currents. The block was non-competitive, required over 100 s to develop and was partially reversible. In oocytes expressing the mutant L248T receptor, A
1-42 activated methyllycaconitine-sensitive currents in a dose-dependent manner. Peptide-evoked unitary events, recorded in outside-out patches, showed single-channel conductances and open duration comparable to ACh-evoked events. A
1-42 had no effect on the currents evoked by glutamate, GABA or glycine in oocytes expressing human or mouse receptors for these transmitters. Muscle nAChRs are also
-BuTx-sensitive and we therefore investigated whether they respond to A
1-42. In human kidney BOSC 23 cells expressing the fetal or adult mouse muscle nAChRs, A
1-42 blocked ACh-evoked whole-cell currents, accelerating their decay. Outside-out single-channel recordings showed that the block was due to a reduced channel open probability and enhanced block upon ACh application. We also report that the inverse peptide A
42-1, but not A
40-1, partially mimicked the effects of the physiological A
1-42 peptide. Possible implications for degenerative neuronal and muscular diseases are discussed.
This article has been cited by other articles:
![]() |
E. A. Gay, R. C. Klein, M. A. Melton, P. J. Blackshear, and J. L. Yakel Inhibition of Native and Recombinant Nicotinic Acetylcholine Receptors by the Myristoylated Alanine-Rich C Kinase Substrate Peptide J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 884 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Magdesian, A. A. Nery, A. H. B. Martins, M. A. Juliano, L. Juliano, H. Ulrich, and S. T. Ferreira Peptide Blockers of the Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Amyloid {beta} J. Biol. Chem., September 2, 2005; 280(35): 31085 - 31090. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Grassi, F. Pagani, G. Spinelli, L. De Angelis, G. Cossu, and F. Eusebi Fusion-independent expression of functional ACh receptors in mouse mesoangioblast stem cells contacting muscle cells J. Physiol., October 15, 2004; 560(2): 479 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Herber, E. G. Severance, J. Cuevas, D. Morgan, and M. N. Gordon Biochemical and Histochemical Evidence of Nonspecific Binding of {alpha}7nAChR Antibodies to Mouse Brain Tissue J. Histochem. Cytochem., October 1, 2004; 52(10): 1367 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wu, Y.-P. Kuo, A. A. George, L. Xu, J. Hu, and R. J. Lukas {beta}-Amyloid Directly Inhibits Human {alpha}4{beta}2-Nicotinic Acetylcholine Receptors Heterologously Expressed in Human SH-EP1 Cells J. Biol. Chem., September 3, 2004; 279(36): 37842 - 37851. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fu and J. H. Jhamandas {beta}-Amyloid Peptide Activates Non-{alpha}7 Nicotinic Acetylcholine Receptors in Rat Basal Forebrain Neurons J Neurophysiol, November 1, 2003; 90(5): 3130 - 3136. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |